 |
|
COVID-19 in immunocompromised children and adolescents
Byung Ok Kwak, Byung Wook Eun
Clin Exp Pediatr. 2023;66(5):182-189. Published online 2023 Apr 18 DOI: https://doi.org/10.3345/cep.2022.00878
|
|
Citations to this article as recorded by
 Unveiling COVID‐19 treatment strategies for immunocompromised individuals: Therapeutic innovations and latest findings
Li‐Teh Liu, Jih‐Jin Tsai
International Journal of Rheumatic Diseases.2024;[Epub] CrossRef Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences.2023; 24(13): 10874. CrossRef Comparison of SARS-CoV-2 seroconversion in children with chronic diseases with healthy children and adults during the first waves of the COVID-19 pandemic
Levi Hoste, Agnieszka Prytula, Jo Dehoorne, Ruth De Bruyne, Stephanie Van Biervliet, Kathleen De Waele, Evelyn Maes, Victoria Bordon, Arnaud Vanlander, Karlien Claes, Johan Vande Walle, Petra Schelstraete, Sabine Van daele, Filomeen Haerynck
Frontiers in Pediatrics.2023;[Epub] CrossRef A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients
Marjan Moghadamnia, Hamid Eshaghi, Hosein Alimadadi, Simin Dashti-Khavidaki
Frontiers in Pediatrics.2023;[Epub] CrossRef Clinical manifestations and outcomes of coronavirus disease 2019 among pediatric liver transplant recipients in the delta and omicron variant pandemic: A retrospective study
Songpon Getsuwan, Sophida Boonsathorn, Sujittra Chaisavaneeyakorn, Napapat Butsriphum, Pornthep Tanpowpong, Chatmanee Lertudomphonwanit, Suporn Treepongkaruna
Medicine.2023; 102(41): e35537. CrossRef
|